Nearly 4 in 10 clinical trials based on false information; FDA routinely ignores blatant science fraud | WHAT REALLY HAPPENED

Nearly 4 in 10 clinical trials based on false information; FDA routinely ignores blatant science fraud

One of the most important responsibilities of the Food and Drug Administration (FDA) in protecting public health is to conduct regular inspections of clinical trial sites to ensure that good clinical practices are being followed. But a new study published in the peer-reviewed journal JAMA Internal Medicine has found that nearly half of all clinical trials are based on false information, and the FDA typically does nothing to address this widespread problem.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA